Overview
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), originally developed for neurological research and studied for its neurotrophic properties. It lacks hormonal activity but retains structural similarity that has driven interest in its effects on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression.
Semax 10mg is planned for the Indonesia catalogue. Register your interest and we will notify you when it becomes available.
Key Research Areas
BDNF Expression Research
Semax is studied for its effect on brain-derived neurotrophic factor (BDNF) expression, a protein central to neuronal survival, growth, and synaptic plasticity research.
Cognitive Pathway Research
Investigated in animal and cell models for its role in cognitive function pathways, including attention and memory-related signalling.
Neuroprotection Models
Studied in neuroprotection research models exploring resistance to hypoxic and ischemic cellular stress.
NGF Signalling Research
Explored for its interaction with nerve growth factor (NGF) pathways, relevant to peripheral and central nervous system research models.
Product Specifications
| Format | Lyophilised powder |
| Quantity | 10mg per vial |
| Purity | >98% (HPLC verified) |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Availability | Launching Soon |
| Research use | In vitro / laboratory use only |